Relationship Between Anemia, and Serum Testosterone Levels in Chronic Obstructive Pulmonary Disease Patients: A Cross-sectional Study
DOI:
https://doi.org/10.31661/gmj.v14i.4088Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a complex condition that can be associated with various comorbidities, including anemia and hormonal imbalances. The relationship between COPD, anemia, and serum testosterone levels has not been thoroughly investigated. To examine the relationship between COPD, anemia, and serum testosterone levels in patients with COPD. Materials and Methods: This cross-sectional study was conducted at Shahid Faghihi and Namazi hospitals in Shiraz, Iran, and included 43 patients with COPD who were admitted to internal medicine and emergency departments between autumn 2018 and autumn 2019. Patients were evaluated for anemia, and serum testosterone levels were measured. Data were analyzed using SPSS version 22. Results: The study included 27 males (62.8%) and 16 females (37.2%). The prevalence of anemia was 48.1% (13/27) in males and 50% (8/16) in females. Total testosterone was significantly higher in males (M=1.74, SD=1.85) compared to females (M=0.47, SD=0.69), P<.001. The study found that females with anemia had significantly higher mean testosterone total levels compared to those without anemia (p=0.047). However, no significant differences were found in testosterone levels between males with and without anemia. While females with anemia had a mean total testosterone level of 0.32 (SD=0.27), while those without anemia had a mean level of 0.61 (SD=0.91), with a significant P-value of 0.047. Conclusion: This study suggests a potential relationship between anemia and serum testosterone levels in female patients with COPD. Further research is needed to confirm these findings and explore the underlying mechanisms.
References
Rosenberg SR, Kalhan R, Mannino dm. Epidemiology of chronic obstructive pulmonary disease: prevalence, morbidity, mortality, and risk factors. in Seminars in respiratory and critical care medicine. 2015;36(4):457469.
https://doi.org/10.1055/s-0035-1555607
PMid:26238634
Germini F, et al. COPD exacerbations in the emergency department: Epidemiology and related costs A retrospective cohort multicentre study from the Italian Society of Emergency Medicine (SIMEU). European Journal of Internal Medicine. 2018; 51: 7479.
https://doi.org/10.1016/j.ejim.2018.01.010
PMid:29371059
Varmaghani M, et al. Death‐specific rate due to asthma and chronic obstructive pulmonary disease in Iran. The clinical respiratory journal. 2018; 12(6): 20752083.
https://doi.org/10.1111/crj.12776
PMid:29405628
Mirbagher A N, Memarian R. The effects of rehabilitation techniques on the pulmonary function tests in moderate severity COPD patients. The Horizon of Medical Sciences. 2009; 14(4): 1925.
Kasper D, Harrison TR. Harrison's principles of internal medicine. McGrawHill: Medical Publishing Division; 2005.
Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. International journal of chronic obstructive pulmonary disease. 2014; 9: 871.
https://doi.org/10.2147/COPD.S49621
PMid:25210449 PMCid:PMC4154888
Mannino DM, et al. Economic burden of COPD in the presence of comorbidities. Chest. 2015; 148(1): 138150.
https://doi.org/10.1378/chest.14-2434
PMid:25675282 PMCid:PMC4493870
Sarkar M, Rajta pn, Khatana j. Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact. Lung India: Official Organ of Indian Chest Society. 2015; 32(2): 142.
https://doi.org/10.4103/0970-2113.152626
PMid:25814799 PMCid:PMC4372868
Cielen N, Maes K, GayanRamirez G. Musculoskeletal disorders in chronic obstructive pulmonary disease. BioMed research international. 2014;2014(1):965764.
https://doi.org/10.1155/2014/965764
PMid:24783225 PMCid:PMC3982416
Jin J, et al. Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease. Medicine. 2016; 95(29):e4219.
https://doi.org/10.1097/MD.0000000000004219
PMid:27442646 PMCid:PMC5265763
Shen TC, Chung WS, Lin CL, Chen CH, Chen WC, Tu CY, et al. The risk of erectile dysfunction in chronic obstructive pulmonary disease: a populationbased cohort study in Taiwan. Medicine (Baltimore). 2015;94(14):e448.
https://doi.org/10.1097/MD.0000000000000448
PMid:25860206 PMCid:PMC4554043
Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(6):17917.
https://doi.org/10.1164/ajrccm.157.6.9705017
PMid:9620907
Svartberg J, Schirmer H, Medbø A, Melbye H, Aasebø U, Sundsfjord J, et al. Reduced pulmonary function is associated with lower levels of endogenous total and free testosterone: the Tromsø study. Eur J Epidemiol. 2007;22(2):10712.
https://doi.org/10.1007/s10654-006-9095-9
PMid:17260104
Laghi F, AntonescuTurcu A, Collins E, Segal J, Tobin MJ. Respiratory and skeletal muscles in hypogonadal men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(6):598605.
https://doi.org/10.1164/rccm.200412-1643OC
PMid:15591465
Van Vliet M, Spruit MA, Verleden G, Kasran A, Van Herck E, Pitta F, et al. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172(9):110511.
https://doi.org/10.1164/rccm.200501-114OC
PMid:16100014
Laghi F, AntonescuTurcu A, Jubran A, Bhanji B, Tobin MJ. Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life. Am J Respir Crit Care Med. 2005;171(7):72833.
https://doi.org/10.1164/rccm.200501-037OC
PMid:15657463
Boutou AK, Hopkinson NS, Polkey MI. Anaemia in chronic obstructive pulmonary disease: an insight into its prevalence and pathophysiology. Clin Sci (Lond). 2015;128(5):28395.
https://doi.org/10.1042/CS20140344
PMid:25394288
Abolhasan H, Maryam T, Mohammad SKA. Epidemiology. of chronic obstructive pulmonary: disease in hospitalized patients; 2019.
Halvani A, Pourfarokh N, Nasiriani K. Quality of life. and related factors in patients: with chronic obstructive pulmonary disease; 2006.
Devereux G. Definition, epidemiology, and risk factors. BMJ. 2006;332(7550):11424.
https://doi.org/10.1136/bmj.332.7550.1142
PMid:16690673 PMCid:PMC1459603
Kasper D, Harrison TR. Harrison's principles of internal medicine. New York: McGrawHill Medical Publishing Division; 2005.
Aliramaei N, et al. A survey on relationship between lung spirometry indices and characteristic features among clients referred to Tohid Hospital in city of Sanandaj in 2011. Life Sci J. 2013;10(4 Suppl): .
Zavareh RHN, Mehdi Zm. Investigating the relationship between the severity of COPD. and anemia in patients referred to: Hazrat Rasool Akram Hospital; 2018.
Attaran Davoud, Rezaei Talab Fariba, Khajeh Deloui Mohammad, Babaian Mahasti, Rezaei Saman. Anemia and its relationship with serum. erythropoietin levels in patients with chronic obstructive pulmonary disease: 2007; Available from: https://sid.ir/paper/806717/fa
Laghi F, AntonescuTurcu A, Jubran A, Bhanji B, Tobin MJ. Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life. Am J Respir Crit Care Med. 2005;171(7):72833.
https://doi.org/10.1164/rccm.200501-037OC
PMid:15657463
Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM, et al. Prevalence and incidence of androgen deficiency in middleaged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2004;89(12):59206.
https://doi.org/10.1210/jc.2003-031719
PMid:15579737
Hashemipour S, et al. Association of hypogonadism with the severity of chronic obstructive pulmonary disease. J Qazvin Univ Med Sci. 2015;19(4):1924.
Zohal MA, Hashemipour S, Karamali N, Farzam SA, Sami R. Association of hypogonadism with the severity of chronic obstructive pulmonary disease. J Qazvin Univ Med Sci. 2015; 19 (4): 1924.
Kaparianos A, Sampsonas F, Karkoulias K, Spiropoulos K, Roussos C, Kolilekas L, et al. Sex hormone alterations and systemic inflammation in a group of male COPD smokers and their correlation with the +138 insA/delA endothelin1 gene polymorphism: a casecontrol study. Eur Rev Med Pharmacol Sci. 2011;15(10):114957.
Balasubramanian V, Naing S. Hypogonadism in chronic obstructive pulmonary disease: incidence and effects. Curr Opin Pulm Med. 2012;18(2):1127.
https://doi.org/10.1097/MCP.0b013e32834feb37
PMid:22234275
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Galen Medical Journal

This work is licensed under a Creative Commons Attribution 4.0 International License.





